<ѻý>New Data on CD40 Ligand Inhibitor for Relapsing MSѻý> Novel agent led to sustained reduction of new lesions at 24 weeks Nov 14, 2023 video
<ѻý>Should MS Patients Stop Treatment as They Age?ѻý> Enrique Alvarez, MD, PhD discusses the challenges of deciding whether patients can safely quit Nov 13, 2023 video
<ѻý>Targeting Chronic Inflammation in Progressive MSѻý> Our panel of experts discuss emerging data in the chronic active inflammation space Nov 10, 2023 video
<ѻý>Biological Age Predicts Dementia; APOE4 and Tau Patterns; AI and MS Brain Changesѻý> News and commentary from the world of neurology and neuroscience Nov 07, 2023
<ѻý>Blood Test Detects MS Disability Worsening a Year Before It Occursѻý> Neurofilament light is elevated before worsening, both with and without relapses Nov 06, 2023
<ѻý>Central Vein Sign as an Imaging Biomarker of Multiple Sclerosisѻý> Our panel of experts discuss emerging data that is leading to new MS diagnostic criteria Nov 03, 2023 video
<ѻý>Probe of Alzheimer's Researcher Halted; Dementia and Triglycerides; Migraine Genesѻý> News and commentary from the world of neurology and neuroscience Oct 31, 2023
<ѻý>Emerging Biomarkers of Multiple Sclerosis in Blood and CSFѻý> While promising, how they apply to individual patients remains a question Oct 27, 2023 video
<ѻý>S1P Receptor Modulator May Boost Cognitive Processing Speed in Early MSѻý> Ozanimod led to test score improvements in interim analysis Oct 19, 2023
<ѻý>BTK Inhibitor Reduces Brain Lesions in Relapsing MSѻý> Subgroup analysis shows brain penetration Oct 19, 2023
<ѻý>Neurofilament Light Predicts MS Worsening in Silent Progressionѻý> NfL changes occurred in advance of, not coincident with, clinical worsening Oct 17, 2023
<ѻý>Path to Multiple Sclerosis Cure on the Horizonѻý> MS field faces immense opportunity to move beyond disease suppression, keynote speaker says Oct 15, 2023
<ѻý>Subcutaneous Ocrelizumab Not Inferior to IV Infusionѻý> Both provided rapid B-cell depletion Oct 14, 2023
<ѻý>Novel Drug Shows Promise in Multiple Sclerosisѻý> CD40 ligand inhibitor leads to sustained reduction of MRI disease activity Oct 13, 2023
<ѻý>Chronic Stress and Dementia; Hormones and Brain Health; Dementia Protection Neurons?ѻý> News and commentary from the world of neurology and neuroscience Oct 03, 2023
<ѻý>Stem Cell Transplants Effective in MSѻý> AHSCT shows long-term benefit in Swedish cohort Sep 29, 2023
<ѻý>Theory Slammed as Pseudoscience; TBI and Cardiovascular Risk; AAN Shares Its Visionѻý> News and commentary from the world of neurology and neuroscience Sep 26, 2023
<ѻý>The Quest to Solve MS: 'It's a Story That's Optimistic'ѻý> Stephen Hauser, MD, talks about The Face Laughs While the Brain Cries Sep 08, 2023
<ѻý>Vaccines Not Linked to MS Flare-Upsѻý> Nationwide French study might clear up a decade of doubts Sep 05, 2023
<ѻý>First Multiple Sclerosis Biosimilar Approvedѻý> Natalizumab-sztn gets a nod from the FDA Aug 25, 2023
<ѻý>Alzheimer's Protector Genes; West Nile and MS; What a 101-Year-Old Neurologist Eatsѻý> News and commentary from the world of neurology and neuroscience Aug 15, 2023
<ѻý>Hand Motions Predict Memory Impairment; APOE4 Smell Loss; Alzheimer's Drug Guidanceѻý> News and commentary from the world of neurology and neuroscience Aug 01, 2023
<ѻý>Stem Cell Medical Tourism Leads to Meningitis in MS Patientѻý> Difficult infection took weeks to identify; doctors warn about unproven treatments Jul 12, 2023
<ѻý>MS Disease Severity Tied to Genetic Variantѻý> Findings mark a significant breakthrough in understanding how MS progresses Jun 28, 2023
<ѻý>Speech Predicts Alzheimer's; Afib and Dementia in Women; Who Gets Lecanemab?ѻý> News and commentary from the world of neurology and neuroscience Jun 27, 2023
<ѻý>Treatment May Delay Earliest MS Eventsѻý> TERIS is the second trial to investigate radiologically isolated syndrome Apr 26, 2023
<ѻý>Novel MS Drug Good as Gold in Phase II Studyѻý> Yes, we mean element no. 79 on the periodic table Apr 25, 2023
<ѻý>Detecting Alzheimer's in Speech; Manipulating CSF in Humans; Gut Microbiome and MSѻý> News and commentary from the world of neurology and neuroscience Apr 04, 2023
<ѻý>Cognitive Impairment in Multiple Sclerosis Tied to Dietѻý> Mediterranean diet was strongest predictor of better cognitive scores Mar 03, 2023
<ѻý>Man Presents With Episodic, One-Sided Facial Paralysisѻý> Uncommon presentation of MS detailed in case report Feb 21, 2023
<ѻý>Epstein-Barr/MS Link; How CBD Curtails Seizures; NIH Finds Rare Neurologic Diseaseѻý> News and commentary from the world of neurology and neuroscience Feb 14, 2023
<ѻý>Viruses Tied to Subsequent Dementia, Other Neurodegenerative Diseasesѻý> Viral encephalitis and Alzheimer's disease showed strongest links Jan 30, 2023
<ѻý>Isolation and Dementia Risk; High-Intensity Exercise and the Brain; Migraine and MSѻý> News and commentary from the world of neurology and neuroscience Jan 17, 2023
<ѻý>Anti-CD20 Agent Gains Approval for Multiple Sclerosisѻý> FDA greenlights ublituximab for relapsing MS Dec 29, 2022
<ѻý>Pragmatic Trials May Help Increase Minority Participation in MS Researchѻý> DELIVER-MS shows racial and ethnic diversity in clinical trials can be improved Nov 02, 2022
<ѻý>Higher Relapse Rate With Rituximab vs Ocrelizumab in MS Registry Dataѻý> Rituximab did not show non-inferiority in comparative effectiveness study Nov 01, 2022
<ѻý>Can First MS Symptoms Be Delayed?ѻý> ARISE trial investigates radiologically isolated syndrome Oct 31, 2022
<ѻý>New Evidence Sheds Light on Stem Cell Transplantation for Progressive MSѻý> Disability, relapses no better than disease-modifying drug Oct 30, 2022
<ѻý>No Excess Pregnancy, Infant Risks With Ocrelizumab for MSѻý> Major congenital anomalies, other adverse outcomes were rare Oct 28, 2022
<ѻý>Off-Label Drug Lowers Relapses in Multiple Sclerosisѻý> Study paves way for rituximab to be considered for MS in some countries Jul 21, 2022